2
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Tumor-Agnostic
1
Conditions
Hodgkin Disease
50
Lymphoma
45
Testicular Neoplasms
13
Teratoma
12
HIV Infections
12
Acquired Immunodeficiency Syndrome
11
Lymphoma, Large B-Cell, Diffuse
10
Lymphoma, Non-Hodgkin
9
Head and Neck Neoplasms
8
Endodermal Sinus Tumor
8
Testicular Germ Cell Tumor
7
Sarcoma, Kaposi
7
Neoplasms
7
Carcinoma, Embryonal
7
Seminoma
6
Lymphoma, Large-Cell, Immunoblastic
6
Lymphoma, Follicular
6
Ovarian Neoplasms
5
Ovarian Germ Cell Cancer
5
Recurrence
4
Neoplasms, Germ Cell and Embryonal
4
Neoplasm Metastasis
4
Carcinoma, Squamous Cell
4
Vulvar Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
3
Breast Neoplasms
3
Teratoma, Testicular
2
Skin Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Drug-Related Side Effects and Adverse Reactions
2
Interventions
Drug Therapy
3
Temozolomide
2
Radiotherapy
2
Radiosurgery
2
Leucovorin
2
Irinotecan
2
Fluorouracil
2
sacubitril and valsartan sodium hydrate drug combination
1
icotinib
1
dostarlimab
1
beta Carotene
1
avelumab
1
alpha-Tocopherol
1
Varenicline
1
Tyrosine Kinase Inhibitors
1
Trastuzumab
1
Tobacco Use Cessation Devices
1
Therapeutics
1
Thalidomide
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Semen Analysis
1
Registries
1
Probiotics
1
Patient Reported Outcome Measures
1
Panitumumab
1
Nicotine Chewing Gum
1
Myofascial Release Therapy
1
Megestrol Acetate
1
Lenalidomide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasms, Second Primary
×
Bleomycin
×
Clear all
NCT03199300
2025-12-11
InvestiCAT
University Medical Center Groningen
Active not recruiting
20 enrolled